In March 2023, Japan’s Ministry of Health and Labor Welfare approved Novo Nordisk’s once-weekly subcutaneous glucagon-like peptide-1
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
The target boundary includes biogenic land?related emissions and removals from bioenergy feedstock
With over 150 leading companies, 300+ topline brands and knowledge-led conference sessions, the event is set to make a grand return to the South
Operating EBITDA increased by 21% to INR 181 crores in Q4 FY23
Cautions against fragmented & siloed efforts in addressing the challenges faced by the world and underlined the need for collaborative efforts to ensure global health security
This plant adds around 60,000 MT of capacity, scaling Jubilant Ingrevia Limited’s overall annual Acetic Anhydride capacity to 210,000 MT
APF Futurity is made from polyolefin materials with no metal parts or recycling disruptors
The company is adding new capabilities of Combi-line for Microsphere, additional Bag line and lyos for the Penem block in Pashamylaram facility in Hyderabad and will be earmarking capital for further building on its Biosimilar CDMO facility
Subscribe To Our Newsletter & Stay Updated
